Search

everythinglearnresearchcommunity

for

Search:↓

Low-level laser therapy is a safe and effective treatment for hair loss.

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Microneedling can effectively promote new hair growth in men with hair loss who didn't improve with traditional treatments.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Minoxidil can reduce functions related to androgen receptors.

Different fields of expertise must work together to better understand hair growth and create effective hair loss treatments.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Female pattern baldness may indicate a higher risk of coronary artery disease.

Hospital staff have a higher rate of hair loss than the general population.

Traditional Chinese Medicine may help treat hair loss but needs more research.

Taohong Siwu Decoction may help treat hair loss by targeting multiple genes and pathways.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

Women with PCOS are more likely to have skin problems like excessive hair, acne, and hair loss.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Hypothyroidism may cause certain types of hair loss.

Certain genes may influence hair loss differently in men and women.

Male pattern baldness does not cause an increased risk of prostate cancer.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Men with male pattern baldness are more likely to have unhealthy blood lipid levels, which could signal other health issues.

A gene mutation in Lama3 is linked to a common type of hair loss.